Abstracts Archive - Page 2224 of 2425 - ACR Meeting Abstracts

Abstract Number: 397 • 2013 ACR/ARHP Annual Meeting
Does Elevated Disease Activity Or Medication Use Influence The Bone Density Of The Prepubertal Offspring In Pregnant Women With Rheumatoid Arthritis?
Florentien D.O. de Steenwinkel¹, Anita C.S. Hokken-Koelega², Johanna Hazes³ and Radboud J.E.M. Dolhain¹, ¹Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, ²Pediatrics, Subdivision of Endocrinology, Erasmus Medical Center- Sophia Children's Hospital, Rotterdam, Netherlands, ³Department of Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands
Background/Purpose: Elevated rheumatoid arthritis disease activity and prednisone use during pregnancy are both associated with a lower bone mineral density (BMD) of the patients, but…
Abstract Number: 398 • 2013 ACR/ARHP Annual Meeting
Does Elevated Disease Activity Or Medication Use Influence The Body Composition Of The Prepubertal Offspring In Pregnant Women With Rheumatoid Arthritis?
Florentien D.O. de Steenwinkel¹, Radboud J.E.M. Dolhain¹, Johanna M.W. Hazes² and Anita C.S. Hokken-Koelega³, ¹Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands, ²Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, ³Pediatrics, Subdivision of Endocrinology, Erasmus Medical Center- Sophia Children's Hospital, Rotterdam, Netherlands
Background/Purpose: Elevated rheumatoid arthritis (RA) disease activity during pregnancy is associated with lower birth weight and rapid post-natal growth. Lower birth weight and rapid post-natal…
Abstract Number: 399 • 2013 ACR/ARHP Annual Meeting
Nausea and Vomiting During Pregnancy and Spontaneous Abortion In Women With Rheumatoid Arthritis
Balambal Bharti¹, Diana L. Johnson² and Christina D. Chambers³, ¹Pediatrics, University of California San Diego, La Jolla, CA, ²University of California San Diego Department of Pediatrics, La Jolla, CA, ³Pediatrics, University of California, San Diego, La Jolla, CA
Background/Purpose: Nausea and Vomiting during Pregnancy (NVP) has been associated with a decreased risk for spontaneous abortion (SAB). However, the Th1/Th2 imbalance that occurs in…
Abstract Number: 360 • 2013 ACR/ARHP Annual Meeting
Visit-To-Visit Variability In Blood Pressure In Patients With Rheumatoid Arthritis (RA) Vs General Population, and Its Impact On Cardiovascular Events and All-Cause Mortality In RA
Elena Myasoedova¹, Cynthia S. Crowson², Abigail B. Green², Eric L. Matteson³ and Sherine E. Gabriel⁴, ¹Internal Medicine and Rheumatology, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ³Rheumatology, Mayo Clinic, Rochester, MN, ⁴Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Blood pressure (BP) variability has been associated with increased risk of cardiovascular (CV) disease and death in the general population. The impact of BP…
Abstract Number: 361 • 2013 ACR/ARHP Annual Meeting
Risk Of Venous Thromboembolism and Use Of Disease-Modifying Antirheumatic Drugs For Rheumatoid Arthritis
Seoyoung C. Kim¹, Daniel H. Solomon^2,3, Jun Liu⁴, Jessica M. Franklin⁵, Robert J. Glynn⁶ and Sebastian Schneeweiss⁷, ¹Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA, ³Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, ⁴Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Boston, MA, ⁵Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, ⁶Brigham and Women's Hospital, Boston, MA, ⁷Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Recent research suggests that rheumatoid arthritis (RA), an autoimmune systemic inflammatory disease, increases the risk of venous thromboembolism (VTE) including pulmonary embolism and deep…
Abstract Number: 362 • 2013 ACR/ARHP Annual Meeting
Management Of Hyperlipidemia In Patients With RA: Results From The Corrona Certain Study
Dimitrios A. Pappas¹, Ani John², Joel M. Kremer³, George W. Reed⁴, Tanya Sommers⁴, Jeffrey D. Greenberg⁵, Ashwini Shewade² and Jeffrey R. Curtis⁶, ¹Columbia University, New York, NY, ²Genentech Inc., South San Francisco, CA, ³Albany Medical College and The Center for Rheumatology, Albany, NY, ⁴CORRONA, Inc., Southborough, MA, ⁵NYU Hospital for Joint Diseases, New York, NY, ⁶7University of Alabama at Birmingham Division of Clinical Immunology and Rheumatology, Birmingham, AL
Background/Purpose: RA is associated with an increased risk for cardiovascular disease (CVD).1 Patients (pts) with RA share similar risk for CVD with non-RA pts who are 10 years older…
Abstract Number: 363 • 2013 ACR/ARHP Annual Meeting
Comparing Myocardial Infarction Risks Associated With Biologics Of Varying Mechanisms Of Action Among Older RA Patients
Jeffrey R. Curtis¹, Huifeng Yun², Jie Zhang³, Fenglong Xie⁴, Lang Chen⁵, Emily Levitan², James Lewis⁶, Timothy Beukelman⁷, Kenneth G. Saag⁸ and Iris Navarro-Millan⁵, ¹University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, Birmingham, AL, ²Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ³Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁴Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, ⁵Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁶Medicine, University of Pennsylvania, Philadelphia, PA, ⁷Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁸Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Anti-TNF biologics have been associated with a reduced risk for acute myocardial infarction (AMI) in some rheumatoid arthritis (RA) populations. The comparative risks for…
Abstract Number: 364 • 2013 ACR/ARHP Annual Meeting
Hyperuricemia As a Risk Factor for Cardiovascular Disease in Patients With Rheumatoid Arthritis
Daniel Kuo¹, Cynthia S. Crowson², Sherine E. Gabriel³ and Eric L. Matteson⁴, ¹Mayo Medical School, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ³Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN, ⁴Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Patients with rheumatoid arthritis (RA) are at increased risk of developing cardiovascular disease (CVD). There is growing evidence that serum uric acid plays an important…
Abstract Number: 365 • 2013 ACR/ARHP Annual Meeting
Oral Calcium Supplementation Is Associated With Subclinical Atherosclerosis In Rheumatoid Arthritis
Shanthi Dhaduvai¹, Laura Geraldino-Pardilla², Jon T. Giles³ and Joan M. Bathon⁴, ¹Division of Rheumatology, Columbia University Medical Center, New York, NY, ²Division of Rheumatology, Columbia University, College of Physicians and Surgeons, New York, NY, ³Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, ⁴Columbia University, New York, NY
Background/Purpose: Recent studies in the general population highlight possible adverse cardiovascular effects with calcium supplementation; however, the association between calcium intake and subclinical markers of…
Abstract Number: 366 • 2013 ACR/ARHP Annual Meeting
Traditional Cardiac Risk Factors Predict Significant Coronary Plaque Burden In Asymptomatic Patients With Rheumatoid Arthritis
George A. Karpouzas¹, Jennifer Malpeso², Tae-Young Choi², Youngju Pak³ and Matthew Budoff², ¹Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, ²Cardiology, Harbor-UCLA Medical Center, Torrance, CA, ³Biostatistics, Harbor-UCLA Medical Center, Torrance, CA
Background/Purpose: Computed tomography angiography (CTA) provides prognostic information in patients with suspected but unknown coronary artery disease (CAD); subjects without plaque had no incident major…
Abstract Number: 367 • 2013 ACR/ARHP Annual Meeting
Cytomegalovirus-Related Immunity Correlates With Myocardial Disease In Rheumatoid Arthritis
John M. Davis III¹, Cynthia S. Crowson², Michael A. Strausbauch³, Terry M. Therneau², Eric L. Matteson¹, Keith L. Knutson³ and Sherine E. Gabriel⁴, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ³Immunology, Mayo Clinic, Rochester, MN, ⁴Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: We recently discovered correlations between a profile of cytokines produced in response to human cytomegalovirus (CMV), poor treatment outcome, and erosive joint damage. The…
Abstract Number: 368 • 2013 ACR/ARHP Annual Meeting
Detrimental Impact Of Long-Term Cumulative Burden Of Rheumatoid Arthritis (RA) Disease Severity On Cardiovascular Outcomes In RA
Elena Myasoedova¹, Birkan Ilhan², Helen Khun³, Eric L. Matteson⁴ and Cynthia S. Crowson³, ¹Internal Medicine and Rheumatology, Mayo Clinic, Rochester, MN, ²Internal Medicine, Marmara University, School of Medicine, Istanbul, Turkey, ³Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Several studies have shown the associations of various measures of rheumatoid arthritis (RA) disease severity with unfavorable cardiovascular (CV) outcomes in RA. The association…
Abstract Number: 369 • 2013 ACR/ARHP Annual Meeting
Prolongation Of QT Interval In Patients With Rheumatoid Arthritis and Its Impact On Mortality: Results From a Population-Based Study
Krati Chauhan¹, Michael Ackerman², Cynthia S. Crowson³, Eric L. Matteson¹ and Sherine E. Gabriel⁴, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Division of Cardiology, Mayo Clinic, Rochester Minnesota, Rochester, MN, ³Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ⁴Health Sciences Research & Div of Rheumatology, Mayo Clinic, Rochester, MN
Background/Purpose: Patients with rheumatoid arthritis (RA) are at increased risk of cardiovascular morbidity and mortality. This risk persists even when RA disease characteristics are taken…
Abstract Number: 370 • 2013 ACR/ARHP Annual Meeting
Shift In Cardiovascular Risk and Lipid Levels In Rheumatoid Arthritis Patients Using ATP-3 Guidelines: Corrona Certain Study
Dimitrios A. Pappas¹, Ani John², Jeffrey R. Curtis^3,4, George W. Reed⁵, Tanya Sommers⁵, Jeffrey D. Greenberg⁶, Ashwini Shewade² and Joel M. Kremer⁷, ¹Columbia University, New York, NY, ²Genentech Inc., South San Francisco, CA, ³Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ⁴University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology, Birmingham, AL, ⁵CORRONA, Inc., Southborough, MA, ⁶Departments of Medicine (Rheum Div) and Hospital for Joint Diseases, New York Hospital for Joint Diseases, New York, NY, ⁷Albany Medical College and The Center for Rheumatology, Albany, NY
Background/Purpose: RA is associated with an increased risk for cardiovascular (CV) disease. Hyperlipidemia is a recognized risk factor for CVD. This study followed the changes…
Abstract Number: 371 • 2013 ACR/ARHP Annual Meeting
Inflammatory Cell Infiltrates In The Heart Of Patients With Coronary Artery Disease With and Without Inflammatory Rheumatic Disease: A Biopsy Study
Jacqueline Kirsti Andersen¹, Ingvild Oma², Ingjerd Lien Kveldstad², Knut Mikkelsen³, Terje Veel⁴, Sven M. Almdahl⁵, Matthew H. Liang⁶, Øystein T. Førre⁷, Morten Fagerland⁸ and Ivana Hollan⁹, ¹Gjøvik University College, Gjøvik, Norway, ²Innlandet Hospital Trust, Lillehammer, Norway, ³Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway, ⁴Feiringklinikken, Feiring, Norway, ⁵Cardiothoracic surgery, University Hospital of North Norway, Tromsø, Norway, ⁶Harvard Medical School, Boston, MA, ⁷Oslo University Hospital, Oslo, Norway, ⁸Department of Biostatistics, Oslo University Hospital, Oslo, Norway, ⁹Rheumatology, Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway
Background/Purpose: Systemic rheumatic diseases (SRDs) are associated with increased cardiovascular (CV) morbidity due to accelerated atherosclerosis. However, SRDs are associated also with cardiac vasculitis that…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].